These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11828153)

  • 1. Dofetilide in patients with congestive heart failure and left ventricular dysfunction: safety aspects and effect on atrial fibrillation. The Danish Investigators of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group.
    Møller M; Torp-Pedersen CT; Køber L
    Congest Heart Fail; 2001; 7(3):146-150. PubMed ID: 11828153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
    Torp-Pedersen C; Møller M; Bloch-Thomsen PE; Køber L; Sandøe E; Egstrup K; Agner E; Carlsen J; Videbaek J; Marchant B; Camm AJ
    N Engl J Med; 1999 Sep; 341(12):857-65. PubMed ID: 10486417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dofetilide to patients with heart failure and left ventricular dysfunction].
    Torp-Pedersen CT; Møller M; Bloch-Thomsen PE; Køber L; Sandøe E; Egstrup K; Agner E; Carlsen JE; Videbaek J
    Ugeskr Laeger; 2000 Oct; 162(44):5948-53. PubMed ID: 11094565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
    McClellan KJ; Markham A
    Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does conversion and prevention of atrial fibrillation enhance survival in patients with left ventricular dysfunction? Evidence from the Danish Investigations of Arrhythmia and Mortality ON Dofetilide/(DIAMOND) study.
    Pedersen OD; Brendorp B; Elming H; Pehrson S; Køber L; Torp-Pedersen C
    Card Electrophysiol Rev; 2003 Sep; 7(3):220-4. PubMed ID: 14739717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.
    Pedersen OD; Bagger H; Keller N; Marchant B; Køber L; Torp-Pedersen C
    Circulation; 2001 Jul; 104(3):292-6. PubMed ID: 11457747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.
    Schmiegelow MD; Pedersen OD; Køber L; Seibæk M; Abildstrøm SZ; Torp-Pedersen C
    BMC Cardiovasc Disord; 2011 May; 11():19. PubMed ID: 21569543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of dofetilide in patients with atrial fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study.
    Singh SN
    Card Electrophysiol Rev; 2003 Sep; 7(3):225-8. PubMed ID: 14739718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial.
    Køber L; Bloch Thomsen PE; Møller M; Torp-Pedersen C; Carlsen J; Sandøe E; Egstrup K; Agner E; Videbaek J; Marchant B; Camm AJ;
    Lancet; 2000 Dec; 356(9247):2052-8. PubMed ID: 11145491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dofetilide: a class III anti-arrhythmic drug for the treatment of atrial fibrillation.
    Torp-Pedersen C; Brendorp B; Køber L
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2695-704. PubMed ID: 11060831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dofetilide on QT dispersion and the prognostic implications of changes in QT dispersion for patients with congestive heart failure.
    Brendorp B; Elming H; Jun L; Køber L; Torp-Pedersen C;
    Eur J Heart Fail; 2002 Mar; 4(2):201-6. PubMed ID: 11959050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after withdrawal of dofetilide in patients with congestive heart failure and a short baseline QTc interval; a follow-up on the Diamond-CHF QT substudy.
    Brendorp B; Torp-Pedersen C; Elming H; Køber L
    Eur Heart J; 2003 Feb; 24(3):274-9. PubMed ID: 12590905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of dofetilide in adult patients with atrial arrhythmias and congenital heart disease: A PACES collaborative study.
    El-Assaad I; Al-Kindi SG; Abraham J; Sanatani S; Bradley DJ; Halsey C; Law IH; Balaji S; Shetty I; Aziz PF
    Heart Rhythm; 2016 Oct; 13(10):2034-9. PubMed ID: 27435587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study.
    Bianconi L; Castro A; Dinelli M; Alboni P; Pappalardo A; Richiardi E; Santini M
    Eur Heart J; 2000 Aug; 21(15):1265-73. PubMed ID: 10924317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery. Dofetilide Post-CABG Study Group.
    Frost L; Mortensen PE; Tingleff J; Platou ES; Christiansen EH; Christiansen N
    Int J Cardiol; 1997 Jan; 58(2):135-40. PubMed ID: 9049678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group.
    Nørgaard BL; Wachtell K; Christensen PD; Madsen B; Johansen JB; Christiansen EH; Graff O; Simonsen EH
    Am Heart J; 1999 Jun; 137(6):1062-9. PubMed ID: 10347332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atrial fibrillation in heart failure].
    Costard-Jäckle A
    Herz; 2002 Jun; 27(4):378-87. PubMed ID: 12187868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.